Capture
Target
Revolutionizing Cancer
Cure
Diagnostics & Treatment
The Optimal Cancer Therapeutic Solution
Pioneering precision medicine through advanced liquid biopsy diagnostics and innovative immunotherapy solutions in the battle against cancer.
From Diagnostics
To Cancer Therapy
Diagnotics
Liquid Biopsy Program
Our groundbreaking CTCeptor empowers the total isolation of circulating tumor cells (CTCs) allowing for a more complete analysis.
Rare Cell Analysis with HyPICC
Hydrogel Pellicle for Lossless Immunocytochemistry (HyPICC), minimizes cell loss exhibiting a retention rate over 97%.
Therapeutics
Receptor Antibody Conjugated Engager (RACE)
Bispecific antibody with a 4-1BB natural ligand binding to both cancer and immune cells. Unlike conventional Bi-Specific antibodies, RACE only targets activated t-cells, providing efficacy and safety.
Membrane Bound Protein (MBP) Tech
With our Membrane Bound Protein (MBP) technology, we have successfully navigated the classic efficacy-safety trade off in therapeutics. This breakthrough enables our MBP-enhanced Natural Killer (NK) cells to demonstrate prolonged survival and heightened infiltration abilities.
